AFFLUENT MEDICAL |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.74 EUR | -0.29% |
|
-4.13% | -5.69% |
| 25/04 | Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 13/03 | AFFLUENT MEDICAL : Invest Securities reiterates its opinion | CF |
| Sales 2023 | - | Sales 2024 * | - | Capitalization | 62.74M 58.02M 5.23B |
|---|---|---|---|---|---|
| Net income 2023 | -16M -14.8M -1.33B | Net income 2024 * | -19M -17.57M -1.58B | EV / Sales 2023 | - |
| Net Debt 2023 * | 10.73M 9.92M 895M | Net Debt 2024 * | 29.57M 27.35M 2.47B | EV / Sales 2024 * | - |
| P/E ratio 2023 |
-3.42
x | P/E ratio 2024 * |
-3.25
x | Employees | 52 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 29.65% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -0.29% | ||
| 1 week | -4.13% | ||
| Current month | -3.33% | ||
| 1 month | -1.14% | ||
| 3 months | +8.75% | ||
| 6 months | +40.32% | ||
| Current year | -5.69% |
1 week
1.73
1.84
1 month
1.641.92
Current year
1.232.13
1 year
0.932.30
3 years
0.938.60
5 years
0.938.60
10 years
0.938.60
| Managers | Title | Age | Since |
|---|---|---|---|
Sébastien Ladet
CEO | Chief Executive Officer | - | 22/22/22 |
Luc Parisot
DFI | Director of Finance/CFO | - | - |
Benjamin Renault
CTO | Chief Tech/Sci/R&D Officer | - | 01/23/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 65 | 27/18/27 | |
| Director/Board Member | - | 27/18/27 | |
| Director/Board Member | - | 19/22/19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/24/12 | 1.74 | -0.29% | 321 |
| 11/24/11 | 1.745 | -0.57% | 3,457 |
| 10/24/10 | 1.755 | 0.00% | 1,101 |
| 07/24/07 | 1.755 | -2.77% | 3,358 |
| 06/24/06 | 1.805 | -1.37% | 3,846 |
Real-time Euronext Paris, June 12, 2024 at 05:23 pm IST
More quotes
Affluent Medical is specialized in the development and production of mini-invasive prostheses used for treating heart disease and urinary incontinence.
Calendar
26/09/2024
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.74
EUR
Average target price
3.367
EUR
Spread / Average Target
+93.49%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.69% | 62.04M | |
| +75.69% | 12.57B | |
| -23.76% | 7.36B | |
| +13.12% | 6.59B | |
| +17.81% | 5.67B | |
| -18.35% | 4.73B | |
| +18.27% | 4.22B | |
| -23.25% | 3.93B | |
| +42.33% | 2.3B | |
| +3.47% | 2.06B |
- Stock Market
- Equities
- AFME Stock
